Aurobindo Pharma on Wednesday mentioned its unit has acquired the primary product approval from the US Meals and Drug Administration for a generic anaesthesia remedy.
The brand new injectable facility of Eugia Steriles, a subsidiary of Eugia Pharma Specialities and a stepdown unit of the corporate, located at Anakapalli District of Andhra Pradesh was inspected by the US FDA from March 28 to April 5 this 12 months.
The plant has now acquired its first product approval from the USFDA for Lidocaine Hydrochloride Injection, Aurobindo Pharma mentioned in a regulatory submitting.Shares of Aurobindo Pharma on Wednesday ended 0.74 per cent down at Rs 1,507.20 apiece on the BSE.